Top of Home Page

Ann Tanabe was appointed CEO of BioHouston in October 2015 after serving four years as the company’s COO. Prior to joining BioHouston in 2011, Ann served as vice president of investor relations at Synthesis Energy Systems, a publicly traded alternative energy company from May 2008 to December 2010.

Prior to this position, Ann served as vice president of corporate communications and investor relations and investor relations director at Encysive Pharmaceuticals, a publicly traded biotechnology company from July 2003 to May 2008.

From October 2000 to July 2003, Ann served as investor relations manager and corporate communications coordinator to Texas Biotechnology, the predecessor company to Encysive Pharmaceuticals. Prior to 2000, Ann held a variety of positions at Rochem Separation Systems. Ann earned a BA degree from Loyola Marymount University. 

Ann is a member of the Cancer Prevention & Research Institute of Texas (CPRIT) Product Development Advisory Committee.  Additionally, Ann is a member of The University of Houston BME Industrial Advisory Board, Rice University’s Professional Science Master’s Program Advisory Board, Houston Community College’s Biotechnology Advisory Committee and External Advisory Committee for the UTMB Health Education Center.  Ann has been an active member of the Houston Chapter of the National Investor Relations Institute (NIRI) since 2000.